Pancreatic Cancer Research

Clinical trialObservationalRecruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177

SEPTRALU, Spanish Series of Patients Treated With the Radionuclide Lutetium177

Outcome
Ongoing
Phase
Observational
Status
Recruiting
Study type
Observational
Start
10 May 2021
Expected end
31 December 2035
Enrollment
5,000 participants
Sites
20
Primary outcomes
Progression Free Survival (PFS); Overall survival (OS); Overall response rate (ORR)
Sponsor type
Academic / other
Results posted
No
Last update
23 December 2022

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice and to learn about the profiles of patients and tumors treated and the results in each type of patient and tumor.

Detailed description public domain (ClinicalTrials.gov)

Patient data will be collected from medical records after obtaining consent and retrospectively.